U.S. Physical Therapy, Inc.
USPH
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $1.2B
$79.35
▲ +0.90%
P/E
466.76
Mkt Cap
$1.2B
52-Wk Range
$58.19–$93.50
52-Week Range
$58.19 - $93.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 6.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive geographic footprint with 591 clinics in 39 states providing scale and market penetration
- Diversified revenue model combining direct patient care with corporate wellness and injury prevention contracts
- Established relationships with Fortune 500 companies, insurers, and healthcare systems creating sticky recurring revenue
- Specialized expertise in orthopedic, sports medicine, and neurological rehabilitation with certified athletic trainers
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Moderate growth ahead
Shift toward outpatient care and away from hospital-based rehabilitation services
Value
Significant premium - growth priced in
Momentum
Hot
+29.4% over 3m
Quality
Thin
Strong fundamentals
Dividend
Solid
2.31% yield
Smart-money signal
Who's buying USPH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $0.75 vs $0.81 consensus (-7.9% surprise). Revenue of $214.1M vs $211.4M expected (+1.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-7.9%
Revenue trend · last 8Q
—
+17%
-2%
-2%
-2%
+12%
+30%
-15%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$168.0M
$180.4M
$152.5M
$164.2M
$164.0M
$202.7M
$198.3M
$139.3M
Margins · last 8Q
Gross
33.0%
Operating
14.0%
Profit
13.8%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 10, 2026
vs Industry
How USPH stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related